Literature DB >> 33706104

MiR-328-3p inhibits lung adenocarcinoma-genesis by downregulation PYCR1.

Jiancong Lu1, Junhong Lin2, Yu Zhou2, Kai Ye2, Changquan Fang2.   

Abstract

BACKGROUND: A vast majority of patients with NSCLC (non-small cell lung cancer) have lung adenocarcinoma (LA), and the survival rate of LA varies from 5% to 75% depending on the severity of this adenocarcinoma. PYCR1 (abnormal pyrroline-5-carboxylate reductase 1) gene and miR-328-3p have been found to be associated with cancer development. However, the underlying mechanism of interaction between miR-328-3p and PYCR1 in LA needs further investigation.
METHODS: The expressions of miR-328-3p and PYCR1 in samples with LA were identified by RT-qPCR. Next, we investigated the targeting relationship between these two biological factors using luciferase assay. CCK-8, BrdU, transwell-migration, and flow cytometry assays were performed to detect cell viability, cell proliferation, cell migration and cell apoptosis in LA cells.
RESULTS: We noticed that miR-328-3p expression was downregulated in LA samples. MiR-328-3p mimic restricted cell proliferation and cell migration, while it enhanced cell apoptosis. Furthermore, the overexpression of PYCR1 promoted the proliferation and migration of LA cells, but it repressed cell apoptosis. Moreover, PYCR1 directly interacted with miR-328-3p in the LA cells, and miR-328-3p restrained the expression of PYCR1, thus suppressing LA tumorigenesis.
CONCLUSION: In summary, our study revealed that miR-328-3p targeting to PYCR1 suppressed the malignancy of LA cells by impeding cell proliferation and migration, while effectively promoting cell apoptosis.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Lung adenocarcinoma; Migration; PYCR1; Proliferation; miR-328–3p

Year:  2021        PMID: 33706104     DOI: 10.1016/j.bbrc.2021.02.029

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.

Authors:  Qi Wang; Zhuolin Xie; Chang Li; Chun Xu; Cheng Ding; Sheng Ju; Jun Chen; Zihan Cui; Chen Chen; Biao Gu; Tengteng Wei; Jun Zhao
Journal:  J Mol Histol       Date:  2022-06-18       Impact factor: 3.156

2.  Circ_0000705 facilitates proline metabolism of esophageal squamous cell carcinoma cells by targeting miR-621/PYCR1 axis.

Authors:  Cui-Juan Qian; Yi-Yang Tong; Lin-Ken Wu; Yi-Chao Wang; Xiao-Sheng Teng; Jun Yao
Journal:  Discov Oncol       Date:  2022-06-22

3.  N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer.

Authors:  Zhenchuan Liu; Tingting Wang; Yunlang She; Kaiqing Wu; Shaorui Gu; Lei Li; Chenglai Dong; Chang Chen; Yongxin Zhou
Journal:  Mol Cancer       Date:  2021-08-20       Impact factor: 27.401

Review 4.  Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.

Authors:  Alexandra N Bogner; Kyle M Stiers; John J Tanner
Journal:  Amino Acids       Date:  2021-05-18       Impact factor: 3.520

5.  MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.

Authors:  Liang Fan; Xing Cao; Yanrong Lei
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis.

Authors:  Wenchang Ni; Zhen Li; Kui Ai
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

7.  Regulation of microRNA miR-197-3p/CDC28 protein kinase regulatory subunit 1B (CKS1B) axis by Circular RNA hsa_circ_0000285 promotes glioma progression.

Authors:  Tao Deng; Yang Liu; Yanlong Yang; Leyong Yuan; Fangfang Liu; Xiaobo Wang; Qiuying Zhang; Mingshui Xie
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  Long non-coding RNA H19 aggravates keloid progression by upregulating SMAD family member 5 expression via miR-196b-5p.

Authors:  Zhichao Li; Cheng Gong; Huiming Wei
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 9.  PYCR, a key enzyme in proline metabolism, functions in tumorigenesis.

Authors:  Yutong Li; Juntao Bie; Chen Song; Minghui Liu; Jianyuan Luo
Journal:  Amino Acids       Date:  2021-07-17       Impact factor: 3.520

10.  MicroRNA miR-502-5p inhibits ovarian cancer genesis by downregulation of GINS complex subunit 2.

Authors:  Lili Zhan; Jing Yang; Yang Liu; Yanxiang Cheng; Hua Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.